Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumanta Kumar Pal

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Molecular Cancer Therapeutics|June 24, 2010
Targeted therapies for non-small cell lung cancer: an evolving landscapeSumanta Kumar Pal, Robert A Figlin, Karen Reckamp
Breast Cancer Research and Treatment|May 27, 2008
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literatureSumanta Kumar Pal, Kathleen Blazer, Jeffrey Weitzel, et al.
Clinical Lung Cancer|December 17, 2008
The role of targeting mammalian target of rapamycin in lung cancerSumanta Kumar Pal, Robert A Figlin, Karen L Reckamp
Expert Opinion on Investigational Drugs|September 18, 2010
Akt inhibitors in clinical development for the treatment of cancerSumanta Kumar Pal, Karen Reckamp, Hua Yu, et al.
Maturitas|August 7, 2010
Cognitive changes associated with endocrine therapy for breast cancerKunal Agrawal, Susan Onami, Joanne E Mortimer, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Therapeutic Sequencing in Metastatic Renal Cell CarcinomaManuel Caitano Maia, Nazli Dizman, Meghan Salgia, et al.
European Urology Focus|September 18, 2020
Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell CarcinomaMichael Staehler, Dena Battle, Sumanta Kumar Pal, et al.
Maturitas|February 9, 2010
Male breast cancer: an update in diagnosis, treatment and molecular profilingSusan Onami, Melanie Ozaki, Joanne E Mortimer, et al.
BJU International|December 17, 2014
Geography: an increasingly important variable in prostate cancer clinical trialsOliver Sartor, Sumanta Kumar Pal, Terhi Hermanson, et al.
Translational Andrology and Urology|January 28, 2016
Current clinical challenges in prostate cancerJonathan L Silberstein, Sumanta Kumar Pal, Brian Lewis, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Molecular Cancer Therapeutics|June 24, 2010
Targeted therapies for non-small cell lung cancer: an evolving landscapeSumanta Kumar Pal, Robert A Figlin, Karen Reckamp
Breast Cancer Research and Treatment|May 27, 2008
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literatureSumanta Kumar Pal, Kathleen Blazer, Jeffrey Weitzel, et al.
Clinical Lung Cancer|December 17, 2008
The role of targeting mammalian target of rapamycin in lung cancerSumanta Kumar Pal, Robert A Figlin, Karen L Reckamp
Expert Opinion on Investigational Drugs|September 18, 2010
Akt inhibitors in clinical development for the treatment of cancerSumanta Kumar Pal, Karen Reckamp, Hua Yu, et al.
Maturitas|August 7, 2010
Cognitive changes associated with endocrine therapy for breast cancerKunal Agrawal, Susan Onami, Joanne E Mortimer, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Therapeutic Sequencing in Metastatic Renal Cell CarcinomaManuel Caitano Maia, Nazli Dizman, Meghan Salgia, et al.
European Urology Focus|September 18, 2020
Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell CarcinomaMichael Staehler, Dena Battle, Sumanta Kumar Pal, et al.
Maturitas|February 9, 2010
Male breast cancer: an update in diagnosis, treatment and molecular profilingSusan Onami, Melanie Ozaki, Joanne E Mortimer, et al.
BJU International|December 17, 2014
Geography: an increasingly important variable in prostate cancer clinical trialsOliver Sartor, Sumanta Kumar Pal, Terhi Hermanson, et al.
Translational Andrology and Urology|January 28, 2016
Current clinical challenges in prostate cancerJonathan L Silberstein, Sumanta Kumar Pal, Brian Lewis, et al.
Pageof 10